COMMUNIQUÉS West-GlobeNewswire

Jason Terris Joins Corizon Health as VP of State Operations
16/09/2019
BRENTWOOD, Tenn., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Jason A. Terris, a 25-year-veteran of corrections and correctional healthcare leadership, has joined Corizon Health as corporate vice president of state operations, [...]
BioCardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal CardiAMP Heart Failure Study as Planned
16/09/2019
SAN CARLOS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent [...]
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award
16/09/2019
MELVILLE, N.Y., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a member of the Company’s [...]
Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 3rd, 2019
16/09/2019
WALTHAM, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia
16/09/2019
– KO-539 is a first-in-class small molecule inhibitor of the menin-MLL interaction – – First-in-human trial to determine MTD, expand to genetic subgroups such as NPM1 – SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Kura [...]
Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen
16/09/2019
Suvodirsen is an investigational stereopure oligonucleotide in development for the treatment of DMD patients amenable to exon 51 skipping Clinical dystrophin data from interim analysis of ongoing OLE study on track for [...]
Checkpoint Therapeutics Announces Data Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
16/09/2019
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Onconova Therapeutics Announces Presentation on Rigosertib at the RAS-Targeted Drug Discovery Summit
16/09/2019
NEWTOWN, Pa., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on [...]
Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies
16/09/2019
SAN DIEGO and TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target [...]
Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23ʳᵈ Annual Scientific Meeting
16/09/2019
Pharmacokinetic/Pharmacodynamic Relationship in Humans Similar to Preclinical Findings Data Support Progression to Phase 2 Clinical Trial in Patients with Obstructive Hypertrophic Cardiomyopathy to Begin in Q4 2019 [...]
VitalHub Announces Exercise of Warrants Led by Institutional Investors
16/09/2019
TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the exercise of warrants for net proceeds of $983,700. The Company announced today the exercise of 5,465,000 [...]
ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit
16/09/2019
TORONTO and CAMBRIDGE, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting [...]
Myriad Announces Research Collaboration with University of Leeds
16/09/2019
Clinical Utility Study will Evaluate the Prolaris® Test in Men with Prostate Cancer SALT LAKE CITY, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and [...]
Emerald Health Therapeutics to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference
16/09/2019
VANCOUVER, British Columbia, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced that it will participate in a panel and be available for 1x1 [...]
Tonix Pharmaceuticals Announces Publication of Paper on Triple Reuptake Inhibitor TNX-1600 (formerly D-578) in the European Journal of Pharmacology
16/09/2019
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the publication of a paper entitled “D- [...]
Medtronic and Novo Nordisk Enter Agreement to Provide Integrated Digital Solutions for People with Diabetes
16/09/2019
The New Collaboration Aims to Develop Solutions Enabling Dosing Data from Novo Nordisk Smart Insulin Pens to be Shared with Medtronic Continuous Glucose Monitoring Devices DUBLIN and BAGSVÆRD, Denmark, Sept. 16, 2019 ( [...]
Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running
16/09/2019
Roche ranked second in the 2019 Dow Jones Sustainability Indices The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Compared to 2018 Roche significantly improved [...]
Pour la onzième année consécutive, Roche se classe parmi les entreprises de santé les plus durables dans le cadre des Dow Jones Sustainability Indices
16/09/2019
Roche s'est classée deuxième dans le cadre des Dow Jones Sustainability Indices Ce classement montre que l’engagement de Roche en faveur du développement durable fait partie intégrante de sa stratégie d’affaires Comparé [...]
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China
16/09/2019
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo ® in China Lugano, Switzerland , and Beijing, China, September 16, 2019 – Helsinn, a Swiss pharmaceutical [...]

Pages